<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "http://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xml:lang="en" article-type="research-article" dtd-version="1.1">
<front>
<journal-meta>
<journal-id journal-id-type="pmc">BIOCELL</journal-id>
<journal-id journal-id-type="nlm-ta">BIOCELL</journal-id>
<journal-id journal-id-type="publisher-id">BIOCELL</journal-id>
<journal-title-group>
<journal-title>BIOCELL</journal-title>
</journal-title-group>
<issn pub-type="epub">1667-5746</issn>
<issn pub-type="ppub">0327-9545</issn>
<publisher>
<publisher-name>Tech Science Press</publisher-name>
<publisher-loc>USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">48076</article-id>
<article-id pub-id-type="doi">10.32604/biocell.2024.048076</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Knockdown of RCN1 contributes to the apoptosis of colorectal cancer via regulating IP3R1</article-title><alt-title alt-title-type="left-running-head">Knockdown of RCN1 contributes to the apoptosis of colorectal cancer via regulating IP3R1</alt-title><alt-title alt-title-type="right-running-head">Knockdown of RCN1 improves colorectal cancer</alt-title>
</title-group>
<contrib-group>
<contrib id="author-1" contrib-type="author">
<name name-style="western"><surname>SHI</surname><given-names>XUAN</given-names></name>
<xref ref-type="aff" rid="aff-1">1</xref>
<xref ref-type="aff" rid="aff-2">2</xref>
</contrib>
<contrib id="author-2" contrib-type="author">
<name name-style="western"><surname>WANG</surname><given-names>YUFEN</given-names></name>
<xref ref-type="aff" rid="aff-1">1</xref>
</contrib>
<contrib id="author-3" contrib-type="author">
<name name-style="western"><surname>LI</surname><given-names>CHENYU</given-names></name>
<xref ref-type="aff" rid="aff-1">1</xref>
</contrib>
<contrib id="author-4" contrib-type="author">
<name name-style="western"><surname>FU</surname><given-names>WANGSHU</given-names></name>
<xref ref-type="aff" rid="aff-3">3</xref>
</contrib>
<contrib id="author-5" contrib-type="author">
<name name-style="western"><surname>ZHANG</surname><given-names>XINYUE</given-names></name>
<xref ref-type="aff" rid="aff-3">3</xref>
</contrib>
<contrib id="author-6" contrib-type="author" corresp="yes">
<name name-style="western"><surname>GONG</surname><given-names>AIXIA</given-names></name>
<xref ref-type="aff" rid="aff-1">1</xref><email>gong0825@aliyun.com</email>
</contrib>
<aff id="aff-1"><label>1</label><institution>Department of Gastroenterology, The First Affiliated Hospital of Dalian Medical University</institution>, <addr-line>Dalian</addr-line>, <country>China</country></aff>
<aff id="aff-2"><label>2</label><institution>Department of Gastroenterology, The First Affiliated Hospital of Jinzhou Medical University</institution>, <addr-line>Jinzhou</addr-line>, <country>China</country></aff>
<aff id="aff-3"><label>3</label><institution>The First Clinical College, Dalian Medical University</institution>, <addr-line>Dalian</addr-line>, <country>China</country></aff>
</contrib-group><author-notes><corresp id="cor1"><label>&#x002A;</label>Address correspondence to: Aixia Gong, <email>gong0825@aliyun.com</email></corresp></author-notes>
<pub-date date-type="collection" publication-format="electronic"><year>2024</year></pub-date>
<pub-date date-type="pub" publication-format="electronic"><day>06</day><month>5</month><year>2024</year></pub-date>
<volume>48</volume>
<issue>5</issue>
<fpage>835</fpage>
<lpage>845</lpage>
<history>
<date date-type="received"><day>27</day><month>11</month><year>2023</year></date>
<date date-type="accepted"><day>06</day><month>2</month><year>2024</year></date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2024 Shi et al.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Shi et al.</copyright-holder>
<license xlink:href="https://creativecommons.org/licenses/by/4.0/">
<license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="TSP_BIOCELL_48076.pdf"></self-uri>
<abstract>
<sec>
<title>Background</title>
<p>The incidence of colorectal cancer (CRC) has been increasing in recent years. Thus, the discovery of factors that can assist in alleviating CRC is urgently warranted.</p>
</sec>
<sec>
<title>Methods</title>
<p>To identify a potential factor involved in the development of CRC, we screened the upregulated genes in tumor tissues through four datasets from an online database. The expression of reticulocalbin 1 (RCN1), a Ca<sup>2&#x002B;</sup>-binding protein, was upregulated in the four datasets. Based on loss-of-function experiments, the effect of RCN1 on cell viability was assessed by Cell Counting Kit-8 (CCK-8) assay. The regulatory effect of RCN1 on apoptosis was evaluated through Annexin V-fluorescein 5-isothiocyanate (FITC)/propidium iodide (PI) staining assay and terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) assay in RKO and SW480 cells. Activation of endoplasmic reticulum (ER) stress signaling pathways was confirmed by estimating the phosphorylation and expression of PRKR-like ER kinase (PERK), inositol-requiring kinase-1 (IRE1), transcription factor 6 (ACT6), and CCAAT/enhancer-binding protein-homologous protein (CHOP). The intracellular Ca<sup>2&#x002B;</sup> homeostasis regulated by RCN1 was determined through the detection of Ca<sup>2&#x002B;</sup> concentration and mitochondrial membrane potential (MMP) measurement. Moreover, whether inositol 1,4,5-trisphosphate receptor type 1 (IP3R1) was involved in the regulation of RCN1 in CRC was verified through the depletion of IP3R1 in RKO cells.</p>
</sec>
<sec>
<title>Results</title>
<p>Knockdown of RCN1 reduced cell viability and facilitated apoptosis in RKO and SW480 cells. Phosphorylation of PERK and IRE1, activation of ATF6, and upregulation of CHOP were induced by the absence of RCN1, suggesting that the unfolded protein response (UPR) was activated in CRC cells. The concentration of Ca<sup>2&#x002B;</sup> in mitochondria was increased after RCN1 depletion, followed by reduction in the MMP and release of cytochrome c from mitochondria to the cytoplasm in RKO and SW480 cells. Moreover, it was demonstrated that IP3R1 mediates the effect of RCN1 on apoptosis induced by ER stress in CRC cells. The downregulation of IP3R1 restored the RCN1 loss-induced apoptosis and the increased Ca<sup>2&#x002B;</sup> concentration.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>Taken together, our results confirmed that silencing of RCN1 disrupted intracellular Ca<sup>2&#x002B;</sup> homeostasis and promoted cell apoptosis caused by TG-induced ER stress by regulating IP3R1 and activating the UPR signaling pathways.</p>
</sec>
</abstract>
<kwd-group kwd-group-type="author">
<kwd>Reticulocalbin 1</kwd>
<kwd>Unfolded protein response</kwd>
<kwd>IP3R1</kwd>
<kwd>Colorectal cancer</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Colorectal cancer (CRC) mostly originates from adenomas in the colon mucosa, driving high cancer-related recurrence and mortality rates worldwide [<xref ref-type="bibr" rid="ref-1">1</xref>]. The development of the malignant phenotype of CRC is controlled by multiple genetic alterations [<xref ref-type="bibr" rid="ref-2">2</xref>]. A large number of patients are already in the middle and late stages when diagnosed, thus missing the optimal window of opportunity for surgical treatment [<xref ref-type="bibr" rid="ref-3">3</xref>]. The other major treatments, including radiotherapy and chemotherapy, have limited impact on the curative effect and prognosis in patients with CRC [<xref ref-type="bibr" rid="ref-4">4</xref>]. Therefore, this study focuses on a factor that can regulate the development of CRC, providing a potential approach for the precise diagnosis and good prognosis of CRC.</p>
<p>Apoptosis is a programmed cell death process regulated by specific factors, which is used to describe the spontaneous death of cells after stimulation [<xref ref-type="bibr" rid="ref-5">5</xref>], including endoplasmic reticulum (ER) stress. The activation of apoptosis is one of the necessary approaches to suppressing the development of various cancers [<xref ref-type="bibr" rid="ref-6">6</xref>]. ER stress-induced unfolded protein response (UPR) to establish ER homeostasis and cytoprotective mechanisms [<xref ref-type="bibr" rid="ref-7">7</xref>,<xref ref-type="bibr" rid="ref-8">8</xref>]. However, when sustained and irreversible ER stress occurs, UPR was activated to induce further ER stress and cell apoptosis through several signaling pathways [<xref ref-type="bibr" rid="ref-9">9</xref>], including the PRKR-like ER kinase (PERK), inositol-requiring kinase-1 (IRE1) and activating transcription factor 6 (ATF6) signaling pathways. The disruption of ER homeostasis and promotes cancer cell apoptosis were also caused by persistent ER stress [<xref ref-type="bibr" rid="ref-10">10</xref>]. Blocking the UPR induced by ER stress may effectively promote apoptosis and inhibit the development of cancer. Previous reports revealed that ER stress-induced apoptosis may inhibit tumor growth <italic>in vivo</italic> in CRC model mice [<xref ref-type="bibr" rid="ref-11">11</xref>]. Thapsigargin (TG), an inhibitor that induces a sustained increase in cytosolic Ca<sup>2&#x002B;</sup> concentration by inhibiting sarcoplasmic/ER Ca<sup>2&#x002B;</sup>-ATPase pumps, disrupts Ca<sup>2&#x002B;</sup> homeostasis in the ER [<xref ref-type="bibr" rid="ref-12">12</xref>]. It has been widely used to induce ER stress and Ca<sup>2&#x002B;</sup> homeostasis disturbances in a variety of cells. Previous reports have demonstrated that TG induced apoptosis through activating ER stress and impairing mitochondrial pathway [<xref ref-type="bibr" rid="ref-13">13</xref>,<xref ref-type="bibr" rid="ref-14">14</xref>]. Therefore, this study focused on exploring the molecules that promote cell apoptosis by regulating the ER stress.</p>
<p>Reticulocalbin 1 (RCN1) localized in the ER is a member of the CREC family, including Ca<sup>2&#x002B;</sup>-binding protein, reticulocalbin (RCNs: RCN1, RCN2, RCN3), stromal cell derived factor 4 (SDF4), ER calcium-binding protein, and calumenin (CALU) [<xref ref-type="bibr" rid="ref-15">15</xref>]. Almost all these proteins contain multiple EF-hand motifs, which present a high affinity to Ca<sup>2&#x002B;</sup>. RCN1 has been reported to regulate Ca<sup>2&#x002B;</sup> activity in the ER lumen and cytoplasm [<xref ref-type="bibr" rid="ref-16">16</xref>,<xref ref-type="bibr" rid="ref-17">17</xref>]. Multiple researches have confirmed that differentially expressed RCN1 is related to the progression of a variety of cancer types. It was found that RCN1 was upregulated in hepatocellular carcinoma [<xref ref-type="bibr" rid="ref-18">18</xref>], lung cancer [<xref ref-type="bibr" rid="ref-19">19</xref>], and kidney cancer [<xref ref-type="bibr" rid="ref-20">20</xref>]. RCN1 promotes drug resistance and a malignant phenotype by activating the c-MYC signaling pathway in hepatocellular carcinoma [<xref ref-type="bibr" rid="ref-21">21</xref>]. Notably, RCN1 has been identified to inhibit ER stress-induced apoptosis in hepatocellular carcinoma cells by regulating Ca<sup>2&#x002B;</sup> homeostasis and the PRKR-like ER kinase (PERK)-CCAAT/enhancer-binding protein-homologous protein (CHOP) pathway [<xref ref-type="bibr" rid="ref-22">22</xref>]. Similar effects of RCN1 on apoptosis have been reported in glioblastoma [<xref ref-type="bibr" rid="ref-23">23</xref>], nasopharyngeal carcinoma [<xref ref-type="bibr" rid="ref-24">24</xref>], and prostate cancer [<xref ref-type="bibr" rid="ref-17">17</xref>] cells. Moreover, it has been shown that RCN1 expression is upregulated in CRC tissues [<xref ref-type="bibr" rid="ref-25">25</xref>]. However, the effects of RCN1 on the apoptosis of CRC cells have not been fully elucidated. Therefore, the purpose of this study was to investigate the regulatory role of RCN1 in ER stress-induced apoptosis of CRC cells.</p>
<p>Through the loss-of-function experiments, knockdown of RCN1 was identified to suppress cell viability and facilitate TG-induced apoptosis in RKO and SW480. The activation of PERK, IRE1 and ATF6 signaling pathways proved that the deletion of RCN1 promoted apoptosis through inducing ER stress and activating UPR. Additionally, intracellular Ca<sup>2&#x002B;</sup> homeostasis was disrupted by silencing of RCN1. Inositol 1,4,5-trisphosphate receptor type 1 (IP3R1) meditated the effect of RCN1 on apoptosis of CRC cells.</p>
</sec>
<sec id="s2">
<title>Methods and Materials</title>
<sec id="s2_1">
<title>Bioinformatics analysis</title>
<p>The CRC datasets GSE32323 [<xref ref-type="bibr" rid="ref-26">26</xref>] and GSE26571 [<xref ref-type="bibr" rid="ref-27">27</xref>] in Gene Expression Omnibus (GEO) database, and colon adenocarcinoma (COAD) and rectum adenocarcinoma (READ) datasets in The Cancer Genome Atlas (TCGA) database were downloaded to analyze the expression levels of differentially expressed genes (DEG) were in normal tissues and tumor tissues. Based on the condition of log<sub>2</sub>fold-change &#x003E; 1 and <italic>p</italic> &#x003C; 0.05, the upregulated DEG were obtained and shown as a Venn diagram.</p>
<p>The Database for Annotation, Visualization and Integrated Discovery online tool was used for gene ontology (GO) analysis. The top 10 terms in biological process, cellular compartment, and molecular function with minimal significance were plotted.</p>
</sec>
<sec id="s2_2">
<title>Tissue collection</title>
<p>The CRC samples and adjacent non-tumor tissues (n &#x003D; 40) were collected from CRC patients, and stored at &#x2212;80&#x00B0;C after freezing in liquid nitrogen for the subsequent experiments. This study has been approved by the Ethics Committee of the First Affiliated Hospital of Jinzhou Medical University (approval number: KYLL202375). All patients provided informed consents for taking part in this study.</p>
</sec>
<sec id="s2_3">
<title>Cell lines and culture conditions</title>
<p>HCT-116, RKO, SW480, DLD-1 and NCM460 cells were purchased from iCell Bioscience Inc. in Shanghai, China. HCT-116 cells were cultured in McCOY&#x2019;s 5A medium (Catalog Number [No.] PM150710) supplied by Procell Life Science &#x0026; Technology Co., Ltd. (Procell) in Wuhan, China. RKO cells were cultured in minimum essential medium (No. 41500, Solarbio, Beijing, China). The RPMI-1640 medium (No. 31800, Solarbio) was used for culturing DLD-1 and NCM460. The above cells were lived in the medium with 1% penicillin (No. C8251, Solarbio), 1% streptomycin (No. S8290, Solarbio) and 10% fetal bovine serum (No. 11011-8611, Tianhang Biotechnology, Huzhou, China) in an incubator with 5% CO<sub>2</sub> at 37&#x00B0;C. L15 medium (No. PM151010, Procell) containing 100 kU/L penicillin, 100 mg/L streptomycin was used for SW480 cells under 100% air conditions. The sequences of short hairpin RNAs (shRNAs) targeting RCN1 were as follows: shRCN1-1: 5&#x2032;-GGATGAGAAGCTAACTAAA-3&#x2032;, shRCN1-2: 5&#x2032;-GGACGGGAAGTTAGACAAA-3&#x2032;. The sequence targeting shRNA targeting IP3R1 (shIP3R1) was 5&#x2032;-GATAGAGATTGTCAGATTA-3&#x2032;. RKO and SW480 were transfected with shRNAs using Lipofectamine 3000 (No. L3000015) purchased from Invitrogen (Carlsbad, CA, USA). At 24 h after transfection, apoptosis of CRC cells was induced by 1 &#x00B5;M TG (No. T863962, Macklin, Shanghai, China).</p>
</sec>
<sec id="s2_4">
<title>Real-time PCR</title>
<p>TRIpure lysis (No. RP1001, BioTeke, Beijing, China) was used to isolate RNA from cells and tissues. These RNA samples were reversely transcribed to cDNA using BeyoRT II M-MLV reverse transcriptase (No. D7160L) purchased from Beyotime (Shanghai, China). Real-time PCR was performed using 2 &#x00D7; Taq PCR MasterMix (No. PC1150, Solarbio) and SYBR Green (No. SY1020, Solarbio) according to the manufacturer&#x2019;s instructions. Sequences of primers used for relative RCN1 mRNA expression detection were listed in Suppl. Table S1. The thermocycling protocol was shown in Suppl. Table S2.</p>
</sec>
<sec id="s2_5">
<title>Western blot</title>
<p>The harvested cells were mixed with the RIPA lysis (No. R0010, Solarbio) and 1 mM PMSF (No. P0100, Solarbio) for extracting proteins. Protein samples were separated through SDS-PAGE and transferred onto a polyvinylidene fluoride (No. IPVH00010, Millipore, Bedford, MA, USA) membrane. The membrane was incubated at 4&#x00B0;C overnight with primary antibodies after blocking for 1 h. Subsequently, the membrane was incubated with secondary antibodies at 37&#x00B0;C for 1 h. The details of antibodies were listed in Suppl. Table S3. Thereafter, the protein bands on the membrane were visualized by employing enhanced chemiluminescence (No. PE0010, Solarbio).</p>
</sec>
<sec id="s2_6">
<title>Cell counting kit-8 (CCK-8)</title>
<p>Cells were collected and seeded in a 96-well plate (5 &#x00D7; 10<sup>3</sup> cells per well). After treatment with TG for 24 h, cells in each well were incubated with CCK-8 solution (10 &#x03BC;L) (No. KGA317, KeyGEN BioTECH, Nanjing, China) at 37&#x00B0;C for 2 h. The optical density value of cells was assessed at 450 nm using a microplate reader (BioTek, Winooski, VT, USA).</p>
</sec>
<sec id="s2_7">
<title>Annexin V-fluorescein 5-isothiocyanate (FITC)/propidium iodide (PI) staining assay</title>
<p>Cell apoptosis was determined using an Annexin V-FITC/PI Apoptosis Detection Kit (No. KGA1102, KeyGEN BioTECH). After centrifugation at 150&#x00D7;g for 5 min, cells from each group were harvested and mixed in binding buffer (500 &#x00B5;L). Cells were then stained with Annexin V-FITC (5 &#x03BC;L) followed by mixing with PI (5 &#x03BC;L) for 15 min in the dark. NovoCyte flow cytometer (Agilent, Santa Clara, CA, USA) was used for measurement of apoptosis rate.</p>
</sec>
<sec id="s2_8">
<title>Terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) assay</title>
<p>Apoptotic cells were stained by the mixture of enzyme solution and label solution in <italic>In Situ</italic> Cell Death Detection Kit (Red) (No. 12156792910, Roche, Basel, Switzerland) at 37&#x00B0;C for 1 h in the dark. Following the rinsing by phosphate buffer saline, cell sections were counterstained with 4,6-diamidino-2-phenylindole (DAPI) (No. D106471-5mg, Aladdin, Shanghai, China) for 5 min. Next, the cells were observed and captured using a microscope (Olympus, Tokyo, Japan).</p>
</sec>
<sec id="s2_9">
<title>Detection of Ca<sup>2&#x002B;</sup> concentration</title>
<p>The intracellular Ca<sup>2&#x002B;</sup> concentration was detected by a Fluo-4 AM fluorescent probe (No. MX4504, Shanghai Maokang Biotechnology Co., Ltd. (Maokang), Shanghai, China). Cells in each group were centrifugated at 150&#x00D7;g for 5 min. Then, they were incubated in serum-free medium containing Fluo-4 AM (4 &#x03BC;M) at 37&#x00B0;C for 30 min. Subsequently, cells were photographed using a BX53 fluorescence microscope (Olympus). For the quantification of Ca<sup>2&#x002B;</sup> concentration, harvested cells was evaluated by flow cytometry.</p>
<p>RhoD-2AM (Red) and Mito-Tracker Green fluorescent probes (No. MX4507, Maokang) were used to label mitochondrial Ca<sup>2&#x002B;</sup> in CRC cells. Cells were incubated in serum-free medium with Rhod-2 AM (4 &#x03BC;M) and Mito-Tracker Green (100 nM, No. MX4309, Maokang) at 37&#x00B0;C for 30 min. Thereafter, cells were observed and captured using the aforementioned fluorescence microscope.</p>
</sec>
<sec id="s2_10">
<title>JC-1 staining</title>
<p>The mitochondrial membrane potential (MMP) in RKO and SW480 cells was detected using the JC-1 staining kit (No. C2006, Beyotime) according to the instructions provided by the manufacturers. Briefly, cells in each group were stained by JC-1 solution (0.5 mL) for 20 min. Cells were collected and resuspended by JC-1 staining buffer (1&#x00D7;) (200 &#x03BC;L). Finally, the MMP was examined by flow cytometry.</p>
</sec>
<sec id="s2_11">
<title>Immunofluorescence staining</title>
<p>Cells were fixed with 4% polyformaldehyde for 15 min. After rinsing by phosphate buffer saline for three times, cells were covered by 0.1% tritonX-100 (No. ST795, Beyotime) for 30 min and then incubated by 1% bull serum albumin (No. A602440-0050, Sangon Biotech, Shanghai, China) for 15 min. Next, cells were incubated with primary antibodies at 4&#x02DA;C overnight, including rabbit anti-RCN1 antibody (dilution 1:500, No. ab210404, Abcam) and mouse anti-IP3R1 antibody (dilution 1:50, No. sc-271197, Santa Cruz). Cells were then incubated with the same dilution ratio (1:1000) of Cy3-conjugated goat anti-rabbit IgG antibody (No. ab6939, Abcam) and FITC-conjugated goat anti-mouse IgG antibody (No. ab6785, Abcam). Next, nuclei of RKO and SW480 cells were counterstained with DAPI (No. D106471-5mg, Aladdin). After treatment with mounting medium (No. S2100, Solarbio), fluorescence in cells was recorded using the aforementioned fluorescence microscope.</p>
</sec>
<sec id="s2_12">
<title>Statistical analysis</title>
<p>Statistical analysis was performed using GraphPad Prism software 8.0 (GraphPad, San Diego, CA, USA). Student&#x2019;s <italic>t</italic>-test was used for analyzing differences between two groups. One-way analysis of variances was performed to evaluate differences among three or more groups. The <italic>p</italic>-values &#x003C; 0.05 indicated statistically significant differences. All data were displayed as the mean &#x00B1; SD.</p>
</sec>
</sec>
<sec id="s3">
<title>Results</title>
<sec id="s3_1">
<title>RCN1 was highly expressed in CRC tissues</title>
<p>To identify genes that potentially regulate the phonotypes of CRC tissues, we downloaded the GSE32323, GSE26571, COAD and READ datasets from the GEO and TCGA databases. The data from these datasets showed that 35 genes were upregulated in CRC tissues (<xref ref-type="fig" rid="fig-1">Fig. 1A</xref>). The top 10 GO pathways in biological process, cellular compartment, and molecular function significantly enriched for these genes are presented in <xref ref-type="fig" rid="fig-1">Fig. 1B</xref>. Previous studies have reported that the CREC protein family participates in the process of multiple diseases, and is associated with the activity and transport of Ca<sup>2&#x002B;</sup> in the cytosol [<xref ref-type="bibr" rid="ref-16">16</xref>]. The expression levels of RCN1, RCN2, RCN3, SDF4 and CALU in GSE32323 are presented as a heatmap. RCN1 showed high expression in CRC tissues (<xref ref-type="fig" rid="fig-1">Fig. 1C</xref>), while its effect on the apoptosis of CRC cells remains unclear. The location of the CREC family genes on the chromosome is displayed in <xref ref-type="fig" rid="fig-1">Fig. 1D</xref>. Additionally, the RCN1 expression in tumor tissue was significantly upregulated in GSE32323 and GSE26571 datasets (<xref ref-type="fig" rid="fig-1">Fig. 1E</xref>). Relative RCN1 mRNA level was assessed in 40 pairs of tumors and non-tumor tissues. RCN1 expression was significantly increased in CRC tumor tissues (<xref ref-type="fig" rid="fig-1">Figs. 1F</xref> and <xref ref-type="fig" rid="fig-1">1G</xref>). Therefore, we confirmed that RCN1 was highly expressed in RCR tissues.</p>
<fig id="fig-1">
<label>Figure 1</label>
<caption>
<title>RCN1 shows high expression in colorectal cancer (CRC) tissues. (A) The overlap of upregulated differentially expressed genes (DEGs) in CRC tissues, whose data came from COAD, READ, GSE32323 and GSE26571 datasets. (B) Gene ontology (GO) enrichment terms of upregulated DEGs. (C) Heatmap showed the expression of CREC family genes in GSE32323. (D) The location of CREC family genes in genome. (E) RCN1 expression in GSE32323 and GSE26571 datasets. (F and G) RCN1 expressions were estimated in tumor and adjacent non-tumor samples.</title></caption>
<graphic mimetype="image" mime-subtype="tif" xlink:href="Biocell-48-48076-f001.tif"/>
</fig>
</sec>
<sec id="s3_2">
<title>Knockdown of RCN1 facilitated the ER stress&#x2011;induced apoptosis of CRC cells</title>
<p>Compared with NCM460 cells, RCN1 expression was obviously increased in CRC cell lines at mRNA and protein levels (<xref ref-type="fig" rid="fig-2">Fig. 2A</xref>). RKO and SW480 cells were transfected with two pieces of shRCN1-1 and shRCN1-2. In the two types of CRC cells, relative mRNA and protein levels of RCN1 were reduced significantly (<xref ref-type="fig" rid="fig-2">Figs. 2B</xref> and <xref ref-type="fig" rid="fig-2">2C</xref>). Additionally, previous reports demonstrated that the apoptosis of RKO and SW480 was promoted by TG-induced ER stress [<xref ref-type="bibr" rid="ref-28">28</xref>,<xref ref-type="bibr" rid="ref-29">29</xref>]. The viability of RKO and SW480 cells was suppressed by the absence of RCN1 (<xref ref-type="fig" rid="fig-2">Fig. 2D</xref>).</p>
<fig id="fig-2">
<label>Figure 2</label>
<caption>
<title>Knockdown of RCN1 suppresses cell viability of CRC cells. (A) RCN1 expression was estimated in NCM460, RKO, SW480, DLD-1 and HCT-116 cell lines using real time PCR. (B and C) The inhibition efficiency of shRCN1-1 and shRCN1-2 was examined in RKO and SW480 cells. (D) Viability of RKO and SW480 cells was assessed using CCK-8 assay.</title></caption>
<graphic mimetype="image" mime-subtype="tif" xlink:href="Biocell-48-48076-f002.tif"/>
</fig>
<p>Moreover, as displayed in <xref ref-type="fig" rid="fig-3">Fig. 3A</xref>, knockdown of RCN1 obviously promoted the apoptosis of RKO and SW480 cell lines. B-cell lymphoma-2 (Bcl-2) protein expression was markedly suppressed by silencing RCN1. In contrast, absence of RCN1 increased the protein expression of Bcl-2-associated X (Bax) (<xref ref-type="fig" rid="fig-3">Fig. 3B</xref>). Furthermore, after transfected with shRCN1s, TUNEL-positive cell rate upregulated remarkably (<xref ref-type="fig" rid="fig-3">Fig. 3C</xref>). Collectively, these findings revealed that loss of RCN1 function suppressed cell viability and further promoted ER stress&#x2011;induced apoptosis of CRC cells.</p>
<fig id="fig-3">
<label>Figure 3</label>
<caption>
<title>Downregulation of RCN1 promotes apoptosis induced by endoplasmic reticulum (ER) stress in CRC cells. (A) The apoptotic CRC cells stained by Annexin V-FITC/PI was detected by flow cytometry. (B) The regulatory effect of RCN1 on Bcl-2 and Bax was assessed by western blot. (C) TUNEL assay examined the regulation of RCN1 downregulation in cell apoptosis. Scale bar &#x003D; 50 &#x03BC;m.</title></caption>
<graphic mimetype="image" mime-subtype="tif" xlink:href="Biocell-48-48076-f003.tif"/>
</fig>
</sec>
<sec id="s3_3">
<title>Depletion of RCN1 promoted ER stress-induced UPR</title>
<p>When defective proteins accumulate abnormally, the PERK, IRE1 and ATF6 signaling pathways are activated to induce further ER stress and cell apoptosis. PERK, IRE1 and ATF6 are crucial factors in the three pathways. These ER stress pathways are activated to mediate the UPR and subsequent cellular stress [<xref ref-type="bibr" rid="ref-30">30</xref>]. Depletion of RCN1 markedly induced the phosphorylation of PERK and IRE1 (<xref ref-type="fig" rid="fig-4">Figs. 4A</xref> and <xref ref-type="fig" rid="fig-4">4B</xref>). Moreover, ATF6 was activated in RKO and SW480 cells. Knockdown of RCN1 also increased the levels of CHOP (<xref ref-type="fig" rid="fig-4">Figs. 4C</xref> and <xref ref-type="fig" rid="fig-4">4D</xref>). The above findings suggested that absence of RCN1 activated the PERK, IRE1 and ATF6 pathways and facilitated UPR in CRC cells.</p>
<fig id="fig-4">
<label>Figure 4</label>
<caption>
<title>Depletion of RCN1 facilitates ER stress-induced UPR. (A and B) Activation of the PERK and IRE1 signaling pathways regulated by knocking down RCN1 was estimated by their phosphorylation levels. (C and D) Activation of the ATF6 signaling pathway was determined by the protein expression of ATF6 and CHOP.</title></caption>
<graphic mimetype="image" mime-subtype="tif" xlink:href="Biocell-48-48076-f004.tif"/>
</fig>
</sec>
<sec id="s3_4">
<title>Silencing of RCN1 disrupted intracellular Ca<sup>2&#x002B;</sup> homeostasis</title>
<p>Concentration of Ca<sup>2&#x002B;</sup> has been considered an important factor in cell apoptosis [<xref ref-type="bibr" rid="ref-31">31</xref>]. Intracellular Ca<sup>2&#x002B;</sup> homeostasis is the basis for maintaining normal cellular structure and function [<xref ref-type="bibr" rid="ref-32">32</xref>]. As depicted in <xref ref-type="fig" rid="fig-5">Figs. 5A</xref> and <xref ref-type="fig" rid="fig-5">5B</xref>, intracellular Ca<sup>2&#x002B;</sup> was labeled with Fluo-4 AM fluorescent probes in RKO and SW480 cells. The intracellular Ca<sup>2&#x002B;</sup> concentration was significantly upregulated by the absence of RCN1, suggesting that a decrease in RCN1 expression disrupted the intracellular Ca<sup>2&#x002B;</sup> homeostasis in CRC cells. Additionally, the mitochondrial Ca<sup>2&#x002B;</sup> was stained with Rhod-2AM, and the staining results demonstrated that mitochondrial Ca<sup>2&#x002B;</sup> was obviously increased in RCN1-silenced RKO and SW480 cells (<xref ref-type="fig" rid="fig-5">Figs. 5C</xref> and <xref ref-type="fig" rid="fig-5">5D</xref>). Moreover, a reduction in MMP was observed after knockdown of RCN1 in CRC cells. Notably, downregulation of shRCN1s significantly increased the MMP in cells with low MMP (<xref ref-type="fig" rid="fig-5">Fig. 5E</xref>). The expression of mitochondrial cytochrome c was reduced in RKO and SW480 cells by knocking down RCN1. Meanwhile, cytochrome c in cytoplasm was significantly upregulated by depletion of RCN1 (<xref ref-type="fig" rid="fig-5">Fig. 5F</xref>). Therefore, the intracellular Ca<sup>2&#x002B;</sup> homeostasis was disrupted by the downregulation of RCN1 in CRC cells.</p>
<fig id="fig-5">
<label>Figure 5</label>
<caption>
<title>Knockdown of RCN1 increases Ca<sup>2&#x002B;</sup> concentration and reduces mitochondrial membrane potential (MMP). (A and B) The intracellular Ca<sup>2&#x002B;</sup> was stained with Fluo-4 AM fluorescent probe in RCN1 silenced-RKO and SW480 cells. Flow cytometry detected the fluorescence intensity. Scale bar &#x003D; 200 &#x03BC;m. (C and D) The RKO and SW480 cells with shRNAs were stained with Rhod-2AM and Mito-Tracker Green fluorescent probes, which marked intracellular Ca<sup>2&#x002B;</sup> and mitochondrial Ca<sup>2&#x002B;</sup>. Scale bar &#x003D; 50 &#x03BC;m. (E) JC-1 assay measured the MMP levels of CRC cells, and cells with low MMP were quantified. (F) The activation of cytochrome c was assessed by detecting its protein expression in mitochondria and cytoplasm.</title></caption>
<graphic mimetype="image" mime-subtype="tif" xlink:href="Biocell-48-48076-f005.tif"/>
</fig>
</sec>
<sec id="s3_5">
<title>IP3R1 mediated the regulatory effect of RCN1 on ER stress-induced apoptosis</title>
<p>Previous research has demonstrated that IP3R1 is involved in the release of ER Ca<sup>2&#x002B;</sup> through interaction with RCN1 [<xref ref-type="bibr" rid="ref-22">22</xref>]. Therefore, we investigated whether the RCN1 regulates ER stress-induced apoptosis by affecting IP3R1. The results of fluorescence co-localization analysis revealed that both RCN1 and IP3R1 were abundant in the cytoplasm of untreated RKO and SW480 cells (<xref ref-type="fig" rid="fig-6">Fig. 6A</xref>). As displayed in <xref ref-type="fig" rid="fig-6">Fig. 6B</xref>, RCN1 and IP3R1 were significantly downregulated by knocking down RCN1, and IP3R1 expression was obviously reduced by silencing IP3R1 in RKO cells. The depletion of IP3R1 further downregulated the protein expression of RCN1 and IP3R1 in the RCN1-reduced RKO cells. Cell apoptosis induced by knocking down RCN1 was suppressed in CRC cells after reduction of IP3R1 (<xref ref-type="fig" rid="fig-6">Fig. 6C</xref>). RCN1 silencing-induced the damage to intracellular Ca<sup>2&#x002B;</sup> homeostasis induced by shRCN1 was reversed by the silencing of IP3R1 (<xref ref-type="fig" rid="fig-6">Fig. 6D</xref>). In conclusion, the findings demonstrated that IP3R1 mediates ER stress-induced apoptosis promoted by RCN1 reduction.</p>
<fig id="fig-6">
<label>Figure 6</label>
<caption>
<title>RCN1 regulates ER stress-induced apoptosis through IP3R1. (A) The co-localization of RCN1 and IP3R1 was assessed by immunofluorescence double staining in untreated RKO and SW480 cells. Scale bar &#x003D; 50 &#x03BC;m. (B) RCN1 and IP3R1 expression levels were detected in RKO cell line under the absence of RCN1 or IP3R1 condition. (C) The effect of knockdown RCN1 or IP3R1 on cell apoptosis was estimated by flow cytometry. (D) The mitochondrial Ca<sup>2&#x002B;</sup> was labeled and evaluated by Rhod-2AM and Mito-Tracker Green fluorescent probe. Scale bar &#x003D; 50 &#x03BC;m.</title></caption>
<graphic mimetype="image" mime-subtype="tif" xlink:href="Biocell-48-48076-f006.tif"/>
</fig>
</sec>
</sec>
<sec id="s4">
<title>Discussion</title>
<p>Findings in this report revealed that RCN1 was upregulated in CRC tissues. Downregulation of RCN1 facilitated the ER stress-induced apoptosis of RKO and SW480 cells. Depletion of RCN1 in CRC cells, and resulted in the disturbance of intracellular Ca<sup>2&#x002B;</sup> homeostasis and MMP. IP3R1 mediates the effect of RCN1 on cell apoptosis. The present findings may provide an available therapeutic approach to intercept the development of CRC.</p>
<p>RCN1 functions as a Ca<sup>2&#x002B;</sup>-binding protein that is stored in ER [<xref ref-type="bibr" rid="ref-33">33</xref>]. It has been reported that a decrease in RCN1 expression obstructs the progress of lung cancer cells [<xref ref-type="bibr" rid="ref-19">19</xref>]. Results from a proteomic analysis confirms that RCN1 was upregulated in renal cell carcinoma tissues and clarifies that RCN1 serves as a potential molecule to regulate the progress of renal cell carcinoma [<xref ref-type="bibr" rid="ref-20">20</xref>]. Moreover, loss of RCN1 function has been reported to induce the apoptosis of prostate cancer cells [<xref ref-type="bibr" rid="ref-17">17</xref>]. Downregulation of RCN1 facilitates apoptosis induced by ER stress in nasopharyngeal carcinoma [<xref ref-type="bibr" rid="ref-24">24</xref>]. RCN1 has been identified as a novel candidate for CRC therapy [<xref ref-type="bibr" rid="ref-34">34</xref>]. However, the function of RCN1 in human CRC warrants further investigation. Through loss-of-function experiments, RCN1 was downregulated in CRC cells. At present, there is no reliable evidence regarding the use of this method in clinical practice. The sequences of shRCN1-1 and shRCN1-2 differed, and both significantly suppressed RCN1 expression in CRC cells. Absence of RCN1 suppressed cell viability and promoted apoptosis induced by ER stress. The flow cytometry results demonstrated that the rate of late apoptosis of RCN1-silenced cells was obviously increased. Therefore, downregulation of RCN1 may serve as an effective approach to inhibiting the development of CRC. These findings indicated that RCN1 was implicated in the malignant phonotypes of CRC.</p>
<p>Whether ER stress-induced apoptosis is regulated by RCN1 in RKO and SW480 cells is still unknown. Therefore, efficient induction of ER stress is necessary in this study. Previous literatures suggests that TG treatment promotes the expression of 78 kDa glucose-regulated protein and cleaved caspase-3 in SW480 cells, and disrupts ER homeostasis, as well as facilitating cell apoptosis [<xref ref-type="bibr" rid="ref-28">28</xref>]. Additionally, the viability of RKO cells treated with TG is inhibited compared with that of control cells. Treatment with TG remarkably induces apoptosis of RKO cells [<xref ref-type="bibr" rid="ref-29">29</xref>]. According to these reports, TG as an effective inducer for ER stress was used in RKO and SW480 cells. Knockdown of RCN1 was involved in ER stress-induced apoptosis of TG-treated CRC cells.</p>
<p>ER is a main storage site for intracellular Ca<sup>2&#x002B;</sup>. ER stress caused by excessive accumulation of defective proteins activates the UPR to induce apoptosis [<xref ref-type="bibr" rid="ref-35">35</xref>]. During the UPR process, the PERK, IRE1, and ATF6 was activated, accompanied by promoting the expression of pro-apoptotic factor CHOP [<xref ref-type="bibr" rid="ref-36">36</xref>]. Our results demonstrated that knockdown of RCN1 in RKO and SW480 cells led to phosphorylation of PERK and IRE1, as well as activation of the ATF6 (<xref ref-type="fig" rid="fig-4">Fig. 4</xref>). Upregulation of CHOP induced by the depletion of RCN1 activated Bax and suppressed Bcl-2 in CRC cells. Our analysis verified that downregulation of RCN1 facilitated apoptosis induced by ER stress via activating the PERK, IRE1, and ATF6 pathways. Bax is an essential factor facilitating mitochondrial membrane permeabilization [<xref ref-type="bibr" rid="ref-30">30</xref>]. Low RCN1 expression induced a reduction of MMP in CRC cells.</p>
<p>IP3R1 is one of the ER-resident Ca<sup>2&#x002B;</sup> release channels [<xref ref-type="bibr" rid="ref-37">37</xref>]. The alteration of Ca<sup>2&#x002B;</sup> concentration in ER has been identified as an important cause of ER stress [<xref ref-type="bibr" rid="ref-38">38</xref>]. RCN1 interacts with IP3R1 at the ER lumen via two EF-hand Ca<sup>2&#x002B;</sup>-binding motifs to suppress the release of ER Ca<sup>2&#x002B;</sup> and cell apoptosis. RCN1 depletion activated UPR through the regulation of IP3R1 and further affected the expression of CHOP [<xref ref-type="bibr" rid="ref-22">22</xref>]. Results in this report confirmed that IP3R1 downregulation suppressed the accumulation of Ca<sup>2&#x002B;</sup> in the mitochondria of RCN1-silenced CRC cells. Moreover, it reversed the promotive effect of RCN1 loss on ER stress-induced apoptosis. It has been reported that IP3R1 promoted the accumulation of mitochondrial Ca<sup>2&#x002B;</sup> to activate the release of cytochrome c and induced cell apoptosis [<xref ref-type="bibr" rid="ref-39">39</xref>]. Our results suggested that downregulation of RCN1 promoted the activation of cytochrome c in RKO and SW480 cells, indicating that RCN1 participated in the apoptosis of CRC cells through affecting IP3R1.</p>
<p>Based on the present findings, RCN1 was identified as a crucial factor for regulating cell death in CRC. Silencing RCN1 may be an effective therapeutic approach to suppressing the development of CRC. Further investigation on RCN1 is warranted to determine its importance as a molecular target and promote its use in clinical practice. Moreover, it is necessary to elucidate the mechanism underlying of RCN1 and its effects on the progression of CRC. This is the direction of our research in the future.</p>
<p>Collectively, the findings displayed in this study clearly demonstrated that depletion of RCN1 inhibited cell viability and promoted ER stress-induced apoptosis via regulating IP3R1 and activating the PERK, IRE1, and ATF6 signaling pathways.</p>
</sec>
<sec sec-type="supplementary-material" id="s5">
<title>Supplementary Materials</title>
<supplementary-material id="SD1">
<media xlink:href="Biocell-48-48076-s001.docx"/>
</supplementary-material>
</sec>
</body>
<back>
<glossary content-type="abbreviations" id="glossary-1">
<title>Abbreviations</title>
<def-list>
<def-item>
<term><bold>ATF6</bold></term>
<def>
<p>Transcription factor 6</p>
</def>
</def-item>
<def-item>
<term><bold>Bax</bold></term>
<def>
<p>Bcl-2-associated X</p>
</def>
</def-item>
<def-item>
<term><bold>Bcl-2</bold></term>
<def>
<p>B-cell lymphoma-2</p>
</def>
</def-item>
<def-item>
<term><bold>CALU</bold></term>
<def>
<p>Calumenin</p>
</def>
</def-item>
<def-item>
<term><bold>CCK-8</bold></term>
<def>
<p>Cell Counting Kit-8</p>
</def>
</def-item>
<def-item>
<term><bold>CHOP</bold></term>
<def>
<p>CCAAT/enhancer-binding protein-homologous protein</p>
</def>
</def-item>
<def-item>
<term><bold>COAD</bold></term>
<def>
<p>Colon adenocarcinoma</p>
</def>
</def-item>
<def-item>
<term><bold>CRC</bold></term>
<def>
<p>Colorectal cancer</p>
</def>
</def-item>
<def-item>
<term><bold>DEGs</bold></term>
<def>
<p>Differentially expressed genes</p>
</def>
</def-item>
<def-item>
<term><bold>ER</bold></term>
<def>
<p>Endoplasmic reticulum</p>
</def>
</def-item>
<def-item>
<term><bold>FITC</bold></term>
<def>
<p>Fluorescein 5-isothiocyanate</p>
</def>
</def-item>
<def-item>
<term><bold>GEO</bold></term>
<def>
<p>Gene expression omnibus</p>
</def>
</def-item>
<def-item>
<term><bold>GO</bold></term>
<def>
<p>Gene ontology</p>
</def>
</def-item>
<def-item>
<term><bold>IP3R1</bold></term>
<def>
<p>Inositol 1,4,5-trisphosphate receptor type 1</p>
</def>
</def-item>
<def-item>
<term><bold>IRE1</bold></term>
<def>
<p>Inositol-requiring kinase-1</p>
</def>
</def-item>
<def-item>
<term><bold>MMP</bold></term>
<def>
<p>Mitochondrial membrane potential</p>
</def>
</def-item>
<def-item>
<term><bold>PERK</bold></term>
<def>
<p>PRKR-like ER kinase</p>
</def>
</def-item>
<def-item>
<term><bold>PI</bold></term>
<def>
<p>Propidium iodide</p>
</def>
</def-item>
<def-item>
<term><bold>RCN</bold></term>
<def>
<p>Reticulocalbin</p>
</def>
</def-item>
<def-item>
<term><bold>READ</bold></term>
<def>
<p>Rectum adenocarcinoma</p>
</def>
</def-item>
<def-item>
<term><bold>SDF4</bold></term>
<def>
<p>Stromal cell derived factor 4</p>
</def>
</def-item>
<def-item>
<term><bold>shRNA</bold></term>
<def>
<p>Short hairpin RNA</p>
</def>
</def-item>
<def-item>
<term><bold>TCGA</bold></term>
<def>
<p>The cancer genome atlas</p>
</def>
</def-item>
<def-item>
<term><bold>TG</bold></term>
<def>
<p>Thapsigargin</p>
</def>
</def-item>
<def-item>
<term><bold>TUNEL</bold></term>
<def>
<p>Terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling</p>
</def>
</def-item>
<def-item>
<term><bold>UPR</bold></term>
<def>
<p>Unfolded protein response</p>
</def>
</def-item>
</def-list>
</glossary>
<ack>
<p>None.</p>
</ack>
<sec>
<title>Funding Statement</title>
<p>The authors received no specific funding for this study.</p>
</sec>
<sec>
<title>Author Contributions</title>
<p>The authors confirm contribution to the paper as follows: study conception and design: Xuan Shi, Aixia Gong; data collection: Xuan Shi, Yufen Wang; analysis and interpretation of results: Chenyu Li, Wangshu Fu, Xinyue Zhang; draft manuscript preparation: Xuan Shi. All authors reviewed the results and approved the final version of the manuscript.</p>
</sec>
<sec sec-type="data-availability">
<title>Availability of Data and Materials</title>
<p>The data generated during and analyzed during the current study are available from the corresponding author on reasonable request.</p>
</sec>
<sec>
<title>Ethics Approval</title>
<p>The study has been approved by the Ethics Committee of the First Affiliated Hospital of Jinzhou Medical University (approval number: KYLL202375). All patients provided informed consents for taking part in this study.</p>
</sec>
<sec sec-type="COI-statement">
<title>Conflicts of Interest</title>
<p>The authors declare that they have no conflicts of interest to report regarding the present study.</p>
</sec>
<sec>
<title>Supplementary Materials</title>
<p>The supplementary materials are available online at <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.32604/biocell.2024.048076">https://doi.org/10.32604/biocell.2024.048076</ext-link>.</p>
</sec>
<ref-list content-type="authoryear">
<title>References</title>
<ref id="ref-1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Siegel</surname> <given-names>R</given-names></string-name>, <string-name><surname>Desantis</surname> <given-names>C</given-names></string-name>, <string-name><surname>Jemal</surname> <given-names>A</given-names></string-name></person-group>. <article-title>Colorectal cancer statistics, 2014</article-title>. <source>CA Cancer J Clin</source>. <year>2014</year>;<volume>64</volume>(<issue>2</issue>):<fpage>104</fpage>&#x2013;<lpage>17</lpage>; <pub-id pub-id-type="pmid">24639052</pub-id></mixed-citation></ref>
<ref id="ref-2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Uzozie</surname> <given-names>AC</given-names></string-name>, <string-name><surname>Selevsek</surname> <given-names>N</given-names></string-name>, <string-name><surname>Wahlander</surname> <given-names>A</given-names></string-name>, <string-name><surname>Nanni</surname> <given-names>P</given-names></string-name>, <string-name><surname>Grossmann</surname> <given-names>J</given-names></string-name>, <string-name><surname>Weber</surname> <given-names>A</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Targeted proteomics for multiplexed verification of markers of colorectal tumorigenesis</article-title>. <source>Mol Cell Proteomics</source>. <year>2017</year>;<volume>16</volume>(<issue>3</issue>):<fpage>407</fpage>&#x2013;<lpage>27</lpage>; <pub-id pub-id-type="pmid">28062797</pub-id></mixed-citation></ref>
<ref id="ref-3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Siegel</surname> <given-names>RL</given-names></string-name>, <string-name><surname>Miller</surname> <given-names>KD</given-names></string-name>, <string-name><surname>Jemal</surname> <given-names>A</given-names></string-name></person-group>. <article-title>Cancer statistics, 2017</article-title>. <source>CA Cancer J Clin</source>. <year>2017</year>;<volume>67</volume>(<issue>1</issue>):<fpage>7</fpage>&#x2013;<lpage>30</lpage>; <pub-id pub-id-type="pmid">28055103</pub-id></mixed-citation></ref>
<ref id="ref-4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Siegel</surname> <given-names>RL</given-names></string-name>, <string-name><surname>Miller</surname> <given-names>KD</given-names></string-name>, <string-name><surname>Goding Sauer</surname> <given-names>A</given-names></string-name>, <string-name><surname>Fedewa</surname> <given-names>SA</given-names></string-name>, <string-name><surname>Butterly</surname> <given-names>LF</given-names></string-name>, <string-name><surname>Anderson</surname> <given-names>JC</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Colorectal cancer statistics, 2020</article-title>. <source>CA Cancer J Clin</source>. <year>2020</year>;<volume>70</volume>(<issue>3</issue>):<fpage>145</fpage>&#x2013;<lpage>64</lpage>; <pub-id pub-id-type="pmid">32133645</pub-id></mixed-citation></ref>
<ref id="ref-5"><label>5.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Kerr</surname> <given-names>JF</given-names></string-name>, <string-name><surname>Harmon</surname> <given-names>BV</given-names></string-name></person-group>. <chapter-title>Definition and incidence of apoptosis: an historical perspective</chapter-title>. In: <person-group person-group-type="editor"><string-name><surname>Tomei</surname> <given-names>LD</given-names></string-name>, <string-name><surname>Cope</surname> <given-names>FO</given-names></string-name></person-group>, <comment>editors</comment>. <source>Apoptosis: the molecular basis of cell death</source>. vol. <volume>3</volume>. <publisher-loc>New York</publisher-loc>: <publisher-name>Cold Spring Harbor Laboratory Press</publisher-name>; <year>1991</year>. p. <fpage>5</fpage>&#x2013;<lpage>29</lpage>.</mixed-citation></ref>
<ref id="ref-6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kashyap</surname> <given-names>D</given-names></string-name>, <string-name><surname>Garg</surname> <given-names>VK</given-names></string-name>, <string-name><surname>Goel</surname> <given-names>N</given-names></string-name></person-group>. <article-title>Intrinsic and extrinsic pathways of apoptosis: role in cancer development and prognosis</article-title>. <source>Adv Protein Chem Struct Biol</source>. <year>2021</year>;<volume>125</volume>:<fpage>73</fpage>&#x2013;<lpage>120</lpage>; <pub-id pub-id-type="pmid">33931145</pub-id></mixed-citation></ref>
<ref id="ref-7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname> <given-names>C</given-names></string-name>, <string-name><surname>Xu</surname> <given-names>J</given-names></string-name>, <string-name><surname>Guo</surname> <given-names>C</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>X</given-names></string-name>, <string-name><surname>Qian</surname> <given-names>C</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>X</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Gambogenic acid induces endoplasmic reticulum stress in colorectal cancer via the aurora a pathway</article-title>. <source>Front Cell Dev Biol</source>. <year>2021</year>;<volume>9</volume>:<fpage>736350</fpage>; <pub-id pub-id-type="pmid">34692693</pub-id></mixed-citation></ref>
<ref id="ref-8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bonsignore</surname> <given-names>G</given-names></string-name>, <string-name><surname>Martinotti</surname> <given-names>S</given-names></string-name>, <string-name><surname>Ranzato</surname> <given-names>E</given-names></string-name></person-group>. <article-title>Endoplasmic reticulum stress and cancer: could unfolded protein response be a druggable target for cancer therapy?</article-title> <source>Int J Mol Sci</source>. <year>2023</year>;<volume>24</volume>(<issue>2</issue>):<fpage>1566</fpage>; <pub-id pub-id-type="pmid">36675080</pub-id></mixed-citation></ref>
<ref id="ref-9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ren</surname> <given-names>J</given-names></string-name>, <string-name><surname>Bi</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Sowers</surname> <given-names>JR</given-names></string-name>, <string-name><surname>Hetz</surname> <given-names>C</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>Y</given-names></string-name></person-group>. <article-title>Endoplasmic reticulum stress and unfolded protein response in cardiovascular diseases</article-title>. <source>Nat Rev Cardiol</source>. <year>2021</year>;<volume>18</volume>(<issue>7</issue>):<fpage>499</fpage>&#x2013;<lpage>521</lpage>; <pub-id pub-id-type="pmid">33619348</pub-id></mixed-citation></ref>
<ref id="ref-10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname> <given-names>R</given-names></string-name>, <string-name><surname>Bian</surname> <given-names>C</given-names></string-name>, <string-name><surname>Gao</surname> <given-names>J</given-names></string-name>, <string-name><surname>Ren</surname> <given-names>H</given-names></string-name></person-group>. <article-title>Endoplasmic reticulum stress in diabetic kidney disease: adaptation and apoptosis after three UPR pathways</article-title>. <source>Apoptosis</source>. <year>2023</year>;<volume>28</volume>(<issue>7&#x2013;8</issue>):<fpage>977</fpage>&#x2013;<lpage>96</lpage>; <pub-id pub-id-type="pmid">37285056</pub-id></mixed-citation></ref>
<ref id="ref-11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Choi</surname> <given-names>SS</given-names></string-name>, <string-name><surname>Lee</surname> <given-names>SK</given-names></string-name>, <string-name><surname>Kim</surname> <given-names>JK</given-names></string-name>, <string-name><surname>Park</surname> <given-names>HK</given-names></string-name>, <string-name><surname>Lee</surname> <given-names>E</given-names></string-name>, <string-name><surname>Jang</surname> <given-names>J</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Flightless-1 inhibits ER stress-induced apoptosis in colorectal cancer cells by regulating Ca<sup>2&#x002B;</sup> homeostasis</article-title>. <source>Exp Mol Med</source>. <year>2020</year>;<volume>52</volume>(<issue>6</issue>):<fpage>940</fpage>&#x2013;<lpage>50</lpage>; <pub-id pub-id-type="pmid">32504039</pub-id></mixed-citation></ref>
<ref id="ref-12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Oslowski</surname> <given-names>CM</given-names></string-name>, <string-name><surname>Urano</surname> <given-names>F</given-names></string-name></person-group>. <article-title>Measuring ER stress and the unfolded protein response using mammalian tissue culture system</article-title>. <source>Methods Enzymol</source>. <year>2011</year>;<volume>490</volume>(<issue>2</issue>):<fpage>71</fpage>&#x2013;<lpage>92</lpage>; <pub-id pub-id-type="pmid">21266244</pub-id></mixed-citation></ref>
<ref id="ref-13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname> <given-names>C</given-names></string-name>, <string-name><surname>Li</surname> <given-names>T</given-names></string-name>, <string-name><surname>Tang</surname> <given-names>S</given-names></string-name>, <string-name><surname>Zhao</surname> <given-names>D</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>C</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>S</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Thapsigargin induces apoptosis when autophagy is inhibited in HepG2 cells and both processes are regulated by ROS-dependent pathway</article-title>. <source>Environ Toxicol Pharmacol</source>. <year>2016</year>;<volume>41</volume>:<fpage>167</fpage>&#x2013;<lpage>79</lpage>; <pub-id pub-id-type="pmid">26708201</pub-id></mixed-citation></ref>
<ref id="ref-14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname> <given-names>F</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>DZ</given-names></string-name>, <string-name><surname>Xu</surname> <given-names>H</given-names></string-name>, <string-name><surname>Li</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>W</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>BL</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Thapsigargin induces apoptosis by impairing cytoskeleton dynamics in human lung adenocarcinoma cells</article-title>. <source>Sci World J</source>. <year>2014</year>;<volume>2014</volume>:<fpage>619050</fpage>.</mixed-citation></ref>
<ref id="ref-15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Zhou</surname> <given-names>X</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>H</given-names></string-name>, <string-name><surname>Sun</surname> <given-names>L</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>B</given-names></string-name>, <string-name><surname>Jiang</surname> <given-names>Y</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>The role of <italic>Eimeria tenella</italic> EtCab protein in the attachment and invasion of host cells</article-title>. <source>Vet Parasitol</source>. <year>2021</year>;<volume>292</volume>:<fpage>109415</fpage>; <pub-id pub-id-type="pmid">33780830</pub-id></mixed-citation></ref>
<ref id="ref-16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Honor&#x00E9;</surname> <given-names>B</given-names></string-name></person-group>. <article-title>The rapidly expanding CREC protein family: members, localization, function, and role in disease</article-title>. <source>Bioessays</source>. <year>2009</year>;<volume>31</volume>(<issue>3</issue>):<fpage>262</fpage>&#x2013;<lpage>77</lpage>.</mixed-citation></ref>
<ref id="ref-17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname> <given-names>X</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>N</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>D</given-names></string-name>, <string-name><surname>Zhu</surname> <given-names>D</given-names></string-name>, <string-name><surname>Yuan</surname> <given-names>Q</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>X</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Downregulation of reticulocalbin-1 differentially facilitates apoptosis and necroptosis in human prostate cancer cells</article-title>. <source>Cancer Sci</source>. <year>2018</year>;<volume>109</volume>(<issue>4</issue>):<fpage>1147</fpage>&#x2013;<lpage>57</lpage>; <pub-id pub-id-type="pmid">29453900</pub-id></mixed-citation></ref>
<ref id="ref-18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yu</surname> <given-names>LR</given-names></string-name>, <string-name><surname>Zeng</surname> <given-names>R</given-names></string-name>, <string-name><surname>Shao</surname> <given-names>XX</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>N</given-names></string-name>, <string-name><surname>Xu</surname> <given-names>YH</given-names></string-name>, <string-name><surname>Xia</surname> <given-names>QC</given-names></string-name></person-group>. <article-title>Identification of differentially expressed proteins between human hepatoma and normal liver cell lines by two-dimensional electrophoresis and liquid chromatography-ion trap mass spectrometry</article-title>. <source>Electrophor</source>. <year>2000</year>;<volume>21</volume>(<issue>14</issue>):<fpage>3058</fpage>&#x2013;<lpage>68</lpage>.</mixed-citation></ref>
<ref id="ref-19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname> <given-names>X</given-names></string-name>, <string-name><surname>Shao</surname> <given-names>W</given-names></string-name>, <string-name><surname>Huang</surname> <given-names>H</given-names></string-name>, <string-name><surname>Feng</surname> <given-names>X</given-names></string-name>, <string-name><surname>Yao</surname> <given-names>S</given-names></string-name>, <string-name><surname>Ke</surname> <given-names>H</given-names></string-name></person-group>. <article-title>Overexpression of RCN1 correlates with poor prognosis and progression in non-small cell lung cancer</article-title>. <source>Hum Pathol</source>. <year>2019</year>;<volume>83</volume>:<fpage>140</fpage>&#x2013;<lpage>8</lpage>; <pub-id pub-id-type="pmid">30172915</pub-id></mixed-citation></ref>
<ref id="ref-20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Giribaldi</surname> <given-names>G</given-names></string-name>, <string-name><surname>Barbero</surname> <given-names>G</given-names></string-name>, <string-name><surname>Mandili</surname> <given-names>G</given-names></string-name>, <string-name><surname>Daniele</surname> <given-names>L</given-names></string-name>, <string-name><surname>Khadjavi</surname> <given-names>A</given-names></string-name>, <string-name><surname>Notarpietro</surname> <given-names>A</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Proteomic identification of Reticulocalbin 1 as potential tumor marker in renal cell carcinoma</article-title>. <source>J Proteomics</source>. <year>2013</year>;<volume>91</volume>:<fpage>385</fpage>&#x2013;<lpage>92</lpage>; <pub-id pub-id-type="pmid">23916412</pub-id></mixed-citation></ref>
<ref id="ref-21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname> <given-names>JW</given-names></string-name>, <string-name><surname>Ma</surname> <given-names>L</given-names></string-name>, <string-name><surname>Liang</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Yang</surname> <given-names>XJ</given-names></string-name>, <string-name><surname>Wei</surname> <given-names>S</given-names></string-name>, <string-name><surname>Peng</surname> <given-names>H</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>RCN1 induces sorafenib resistance and malignancy in hepatocellular carcinoma by activating c-MYC signaling via the IRE1&#x03B1;-XBP1s pathway</article-title>. <source>Cell Death Discov</source>. <year>2021</year>;<volume>7</volume>(<issue>1</issue>):<fpage>298</fpage>; <pub-id pub-id-type="pmid">34663798</pub-id></mixed-citation></ref>
<ref id="ref-22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Xu</surname> <given-names>S</given-names></string-name>, <string-name><surname>Xu</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>L</given-names></string-name>, <string-name><surname>Fang</surname> <given-names>Q</given-names></string-name>, <string-name><surname>Song</surname> <given-names>S</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>J</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>RCN1 suppresses ER stress-induced apoptosis via calcium homeostasis and PERK-CHOP signaling</article-title>. <source>Oncogenesis</source>. <year>2017</year>;<volume>6</volume>(<issue>3</issue>):<fpage>e304</fpage>; <pub-id pub-id-type="pmid">28319095</pub-id></mixed-citation></ref>
<ref id="ref-23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gomez</surname> <given-names>J</given-names></string-name>, <string-name><surname>Areeb</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Stuart</surname> <given-names>SF</given-names></string-name>, <string-name><surname>Nguyen</surname> <given-names>HPT</given-names></string-name>, <string-name><surname>Paradiso</surname> <given-names>L</given-names></string-name>, <string-name><surname>Zulkifli</surname> <given-names>A</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>EGFRvIII promotes cell survival during endoplasmic reticulum stress through a reticulocalbin 1-dependent mechanism</article-title>. <source>Cancers</source>. <year>2021</year>;<volume>13</volume>(<issue>6</issue>).</mixed-citation></ref>
<ref id="ref-24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Huang</surname> <given-names>ZH</given-names></string-name>, <string-name><surname>Qiao</surname> <given-names>J</given-names></string-name>, <string-name><surname>Feng</surname> <given-names>YY</given-names></string-name>, <string-name><surname>Qiu</surname> <given-names>MT</given-names></string-name>, <string-name><surname>Cheng</surname> <given-names>T</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>J</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Reticulocalbin-1 knockdown increases the sensitivity of cells to Adriamycin in nasopharyngeal carcinoma and promotes endoplasmic reticulum stress-induced cell apoptosis</article-title>. <source>Cell Cycle</source>. <year>2020</year>;<volume>19</volume>(<issue>13</issue>):<fpage>1576</fpage>&#x2013;<lpage>89</lpage>; <pub-id pub-id-type="pmid">32436770</pub-id></mixed-citation></ref>
<ref id="ref-25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ning</surname> <given-names>J</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>M</given-names></string-name>, <string-name><surname>Shen</surname> <given-names>J</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>D</given-names></string-name>, <string-name><surname>Gao</surname> <given-names>L</given-names></string-name>, <string-name><surname>Li</surname> <given-names>H</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Expression signature and prognostic value of CREC gene family in human colorectal cancer</article-title>. <source>BMC Cancer</source>. <year>2023</year>;<volume>23</volume>(<issue>1</issue>):<fpage>878</fpage>; <pub-id pub-id-type="pmid">37723418</pub-id></mixed-citation></ref>
<ref id="ref-26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Khamas</surname> <given-names>A</given-names></string-name>, <string-name><surname>Ishikawa</surname> <given-names>T</given-names></string-name>, <string-name><surname>Shimokawa</surname> <given-names>K</given-names></string-name>, <string-name><surname>Mogushi</surname> <given-names>K</given-names></string-name>, <string-name><surname>Iida</surname> <given-names>S</given-names></string-name>, <string-name><surname>Ishiguro</surname> <given-names>M</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Screening for epigenetically masked genes in colorectal cancer using 5-Aza-2&#x0027;-deoxycytidine, microarray and gene expression profile</article-title>. <source>Cancer Genomics Proteomics</source>. <year>2012</year>;<volume>9</volume>(<issue>2</issue>):<fpage>67</fpage>&#x2013;<lpage>75</lpage>; <pub-id pub-id-type="pmid">22399497</pub-id></mixed-citation></ref>
<ref id="ref-27"><label>27.</label><mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Leydold</surname> <given-names>SM</given-names></string-name>, <string-name><surname>Seewald</surname> <given-names>M</given-names></string-name>, <string-name><surname>Stratowa</surname> <given-names>C</given-names></string-name>, <string-name><surname>Kaserer</surname> <given-names>K</given-names></string-name>, <string-name><surname>Sommergruber</surname> <given-names>W</given-names></string-name>, <string-name><surname>Kraut</surname> <given-names>N</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Peroxireduxin-4 is over-expressed in colon cancer and its down-regulation leads to apoptosis</article-title>. <source>Cancer Growth and Metastasis</source>. <year>2011</year>;<volume>4</volume>:<comment>CGM.S6584</comment>.</mixed-citation></ref>
<ref id="ref-28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liang</surname> <given-names>G</given-names></string-name>, <string-name><surname>Fang</surname> <given-names>X</given-names></string-name>, <string-name><surname>Yang</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Song</surname> <given-names>Y</given-names></string-name></person-group>. <article-title>Knockdown of CEMIP suppresses proliferation and induces apoptosis in colorectal cancer cells: downregulation of GRP78 and attenuation of unfolded protein response</article-title>. <source>Biochem Cell Biol</source>. <year>2018</year>;<volume>96</volume>(<issue>3</issue>):<fpage>332</fpage>&#x2013;<lpage>41</lpage>; <pub-id pub-id-type="pmid">29024602</pub-id></mixed-citation></ref>
<ref id="ref-29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname> <given-names>G</given-names></string-name>, <string-name><surname>Han</surname> <given-names>J</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>G</given-names></string-name>, <string-name><surname>Wu</surname> <given-names>X</given-names></string-name>, <string-name><surname>Huang</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Wu</surname> <given-names>M</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>ERO1&#x03B1; mediates endoplasmic reticulum stress-induced apoptosis via microRNA-101/EZH2 axis in colon cancer RKO and HT-29 cells</article-title>. <source>Hum Cell</source>. <year>2021</year>;<volume>34</volume>(<issue>3</issue>):<fpage>932</fpage>&#x2013;<lpage>44</lpage>; <pub-id pub-id-type="pmid">33559868</pub-id></mixed-citation></ref>
<ref id="ref-30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Keramidas</surname> <given-names>P</given-names></string-name>, <string-name><surname>Papachristou</surname> <given-names>E</given-names></string-name>, <string-name><surname>Papi</surname> <given-names>RM</given-names></string-name>, <string-name><surname>Mantsou</surname> <given-names>A</given-names></string-name>, <string-name><surname>Choli-Papadopoulou</surname> <given-names>T</given-names></string-name></person-group>. <article-title>Inhibition of PERK kinase, an orchestrator of the unfolded protein response (UPR), significantly reduces apoptosis and inflammation of lung epithelial cells triggered by SARS-CoV-2 ORF3a protein</article-title>. <source>Biomedicines</source>. <year>2023</year>;<volume>11</volume>(<issue>6</issue>):<fpage>1585</fpage>; <pub-id pub-id-type="pmid">37371681</pub-id></mixed-citation></ref>
<ref id="ref-31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bahar</surname> <given-names>E</given-names></string-name>, <string-name><surname>Kim</surname> <given-names>H</given-names></string-name>, <string-name><surname>Yoon</surname> <given-names>H</given-names></string-name></person-group>. <article-title>ER stress-mediated signaling: action potential and Ca<sup>2&#x002B;</sup> as key players</article-title>. <source>Int J Mol Sci</source>. <year>2016</year>;<volume>17</volume>(<issue>9</issue>):<fpage>1558</fpage>; <pub-id pub-id-type="pmid">27649160</pub-id></mixed-citation></ref>
<ref id="ref-32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Luan</surname> <given-names>S</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>C</given-names></string-name></person-group>. <article-title>Calcium signaling mechanisms across kingdoms</article-title>. <source>Annu Rev Cell Dev Biol</source>. <year>2021</year>;<volume>37</volume>:<fpage>311</fpage>&#x2013;<lpage>40</lpage>; <pub-id pub-id-type="pmid">34375534</pub-id></mixed-citation></ref>
<ref id="ref-33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rybarski</surname> <given-names>M</given-names></string-name>, <string-name><surname>Mrohs</surname> <given-names>D</given-names></string-name>, <string-name><surname>Osenberg</surname> <given-names>K</given-names></string-name>, <string-name><surname>Hemmersbach</surname> <given-names>M</given-names></string-name>, <string-name><surname>Pfeffel</surname> <given-names>K</given-names></string-name>, <string-name><surname>Steinkamp</surname> <given-names>J</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Loss of parkin causes endoplasmic reticulum calcium dyshomeostasis by upregulation of reticulocalbin 1</article-title>. <source>Eur J Neurosci</source>. <year>2023</year>;<volume>57</volume>(<issue>5</issue>):<fpage>739</fpage>&#x2013;<lpage>61</lpage>; <pub-id pub-id-type="pmid">36656174</pub-id></mixed-citation></ref>
<ref id="ref-34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Watanabe</surname> <given-names>M</given-names></string-name>, <string-name><surname>Takemasa</surname> <given-names>I</given-names></string-name>, <string-name><surname>Kawaguchi</surname> <given-names>N</given-names></string-name>, <string-name><surname>Miyake</surname> <given-names>M</given-names></string-name>, <string-name><surname>Nishimura</surname> <given-names>N</given-names></string-name>, <string-name><surname>Matsubara</surname> <given-names>T</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>An application of the 2-nitrobenzenesulfenyl method to proteomic profiling of human colorectal carcinoma: a novel approach for biomarker discovery</article-title>. <source>Proteomics Clin Appl</source>. <year>2008</year>;<volume>2</volume>(<issue>6</issue>):<fpage>925</fpage>&#x2013;<lpage>35</lpage>; <pub-id pub-id-type="pmid">21136890</pub-id></mixed-citation></ref>
<ref id="ref-35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Marciniak</surname> <given-names>SJ</given-names></string-name>, <string-name><surname>Chambers</surname> <given-names>JE</given-names></string-name>, <string-name><surname>Ron</surname> <given-names>D</given-names></string-name></person-group>. <article-title>Pharmacological targeting of endoplasmic reticulum stress in disease</article-title>. <source>Nat Rev Drug Discov</source>. <year>2022</year>;<volume>21</volume>(<issue>2</issue>):<fpage>115</fpage>&#x2013;<lpage>40</lpage>; <pub-id pub-id-type="pmid">34702991</pub-id></mixed-citation></ref>
<ref id="ref-36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wek</surname> <given-names>RC</given-names></string-name></person-group>. <article-title>Role of eIF2&#x03B1; kinases in translational control and adaptation to cellular stress</article-title>. <source>Cold Spring Harb Perspect Biol</source>. <year>2018</year>;<volume>10</volume>(<issue>7</issue>):<fpage>a03287</fpage>.</mixed-citation></ref>
<ref id="ref-37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rieusset</surname> <given-names>J</given-names></string-name>, <string-name><surname>Fauconnier</surname> <given-names>J</given-names></string-name>, <string-name><surname>Paillard</surname> <given-names>M</given-names></string-name>, <string-name><surname>Belaidi</surname> <given-names>E</given-names></string-name>, <string-name><surname>Tubbs</surname> <given-names>E</given-names></string-name>, <string-name><surname>Chauvin</surname> <given-names>MA</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Disruption of calcium transfer from ER to mitochondria links alterations of mitochondria-associated ER membrane integrity to hepatic insulin resistance</article-title>. <source>Diabetologia</source>. <year>2016</year>;<volume>59</volume>(<issue>3</issue>):<fpage>614</fpage>&#x2013;<lpage>23</lpage>; <pub-id pub-id-type="pmid">26660890</pub-id></mixed-citation></ref>
<ref id="ref-38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhou</surname> <given-names>F</given-names></string-name>, <string-name><surname>Gao</surname> <given-names>H</given-names></string-name>, <string-name><surname>Shang</surname> <given-names>L</given-names></string-name>, <string-name><surname>Li</surname> <given-names>J</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>M</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>S</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Oridonin promotes endoplasmic reticulum stress via TP53-repressed TCF4 transactivation in colorectal cancer</article-title>. <source>J Exp Clin Cancer Res</source>. <year>2023</year>;<volume>42</volume>(<issue>1</issue>):<fpage>150</fpage>; <pub-id pub-id-type="pmid">37337284</pub-id></mixed-citation></ref>
<ref id="ref-39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yuan</surname> <given-names>M</given-names></string-name>, <string-name><surname>Gong</surname> <given-names>M</given-names></string-name>, <string-name><surname>He</surname> <given-names>J</given-names></string-name>, <string-name><surname>Xie</surname> <given-names>B</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Meng</surname> <given-names>L</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>IP3R1/GRP75/VDAC1 complex mediates endoplasmic reticulum stress-mitochondrial oxidative stress in diabetic atrial remodeling</article-title>. <source>Redox Biol</source>. <year>2022</year>;<volume>52</volume>:<fpage>102289</fpage>; <pub-id pub-id-type="pmid">35344886</pub-id></mixed-citation></ref>
</ref-list>
</back>
</article>





